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vs 20.912.9 weeks for the BPL group, p¼0.23). The multivariate logistic
regression models correcting for relevant confounders refuted the unadjusted
analyses and showed study groups to have similar success rates (respectively,
OR 1.41, CI 0.97-2.05, p¼0.07 for the LBR after the subsequent ET and OR
1.27, CI 0.90-1.80, p¼0.18 for the LBR after one year).
CONCLUSIONS: Patients with a BPL versus a negative pregnancy test
following the first fresh ET have comparable subsequent reproductive outcomes. When experiencing a BPL after a first fresh ET, patients can be reassured that they do not seem to have an increased risk of encountering another
early pregnancy failure when compared to patients having a negative hCG
test and that they have similar chances of reaching a successful pregnancy
following the subsequent ET, but also at the timepoint of one year and this
within a comparable time window.
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BRINGING INFORMED CONSENT TO THE 21ST CENTURY – THE IMPACT OF AN ONLINE RESOURCE
AND CONSENT PROCESS ON FERTILITY PATIENT
PERCEPTIONS. Abigail
L.
Bernard,
MD,1
Ashley K. Barbour, MPhys,2
Jody L. Madeira, Ph.D., J.D.,3
Steven R. Lindheim, M.D.,4 Linnea R. Goodman, MD.1 1University of North
Carolina Raleigh, NC; 2Brody School of Medicine at East Carolina University, Greenville, NC; 3Professor of Law, Bloomington, IN; 4Wright State University, Dayton, OH.
OBJECTIVE: To determine if the use of a multimedia electronic (e)learning resource and e-consent process influences patients’ perception of
their treatment team and eases the administrative burden.
DESIGN: Prospective randomized controlled trial.
MATERIALS AND METHODS: Patients undergoing their first intrauterine insemination (IUI) or in-vitro fertilization (IVF) cycle were randomized
to receive standard fertility counseling and sign paper consents with their
physician and nurse team (conventional group) or to receive standard counseling plus access to an interactive multimedia e-learning and e-consent platform (EngagedMD group). Surveys were administered prior to treatment
(T1) and at cycle completion (T2) to assess their treatment experience,
perception of their treatment team, and the informed consent (IC) process.
A therapeutic index (TI) score was generated based on the sum of patients’
responses to six questions including how much they agreed or disagreed
with statements regarding their physician/nursing team. Additionally, patients were surveyed about their perception of IC in general and their experience with the consent process. The six physicians and four nurses involved
in patient care were surveyed regarding their experience during the study.
Statistics were performed using the student’s t-test and Chi-squared test
where appropriate.
RESULTS: Demographics for the 77 patients (42¼IVF and 35¼IUI)
including age, duration of infertility and education level were similar between the conventional and EngagedMD groups. Calculated TI scores revealed no difference at T1 (p ¼ 0.81) or T2 (p ¼ 0.68) between the
conventional and EngagedMD groups. Regarding IC, there was no difference
between patients’ summed responses in the conventional and EngagedMD
groups. Of those that used the online platform, most patients agreed that it
was helpful (92.5%), user-friendly (81.4%), and would recommend it to a
friend (85.2%). Of those that signed consents online, 25 of 27 (92.5%) patients preferred this over standard paper consents. When rating overall
fertility treatment satisfaction on a 1-100 scale, there was no difference between those that used EngagedMD and those that did not (85.2 +/- 21/1 vs.
83.8 +/- 18.5; p ¼ 0.82). While none of the physicians surveyed felt that
the addition of e-consents aided in patient understanding, all physicians
and nurses felt that having e-consents was a valuable addition to the practice
and made the process easier.
CONCLUSIONS: The addition of an online learning and consent platform
did not significantly impact patients’ perception of their treatment team, nor
their overall perception of the informed consent process. However, patients
and providers using the online consent process agreed that it was a valuable
addition to streamline the consent process.
References: none
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DECISION REGRET AFTER AUTOLOGOUS IN VITRO
FERTILIZATION IN WOMEN AGE 42 AND
OVER. David Huang, MD, Eleni Greenwood Jaswa, MD,
MSc, Marcelle I. Cedars, MD, Heather G. Huddleston, MD.
University of California San Francisco Department of Obstetrics and Gynecology, San Francisco, CA.
OBJECTIVE: An increasing number of women greater than or equal to 42
years old choose to pursue autologous IVF (aIVF) despite persistently low
success rates in this age group. Few data exist on these patients’ reflections
on their decision after undergoing aIVF. We aim to describe the level of decision regret in women age 42 and over who underwent aIVF and identify
factors associated with moderate/severe regret.
DESIGN: Retrospective cohort survey study.
MATERIALS AND METHODS: Between 2012-2018, 463 women greater
than or equal to 42 years old underwent aIVF at a single academic institution.
Patients were invited to participate in an online survey that inquired their experience with IVF. The survey contained 38-items, including the validated Decision Regret Scale (DRS) as well as items examining demographics, perceived
adequacy of counseling, reproductive outcomes, and impact of IVF on one’s
relationship, career, and philosophy of life. Our primary outcome was the
DRS decision regret score: 0 (no regret), 1-25 (mild regret), and >25 (moderate/severe regret). Demographic and treatment-related variables were compared
between patients who demonstrated moderate/severe regret and those with no/
mild regret using the Student t-test or the chi-square test as appropriate.
RESULTS: Of the 463 eligible participants, 70 (15.1%) obtained at least
one live birth from aIVF and 393 (84.9%) did not. The survey was completed
by 62 (13.4%) patients; response rate was 37.1% (n¼26) in those who obtained a live birth versus 9.2% (n¼36) in those who did not. Mean age was
43.1y at time of IVF (range 42-47y), and the elapsed time between survey
and last IVF averaged 4.7y (range 1.0-8.1y). Of the 62 respondents, 40.3%
(n¼25) had no regret, 33.9% (n¼21) had mild regret, and 25.8% (n¼16)
had moderate/severe regret after aIVF. Median DRS score was 7.5 (interquartile range 0-28.75) and the mean was 15.3 (range 0-70). Age at initiating IVF,
income, educational attainment, elapsed time from last IVF, and number of
aIVF cycles were not associated with higher degree of regret. Having no insurance coverage for IVF was associated with increased regret, though the
association did not reach statistical significance (p¼0.06). Having no live
births was associated with increased regret (p<0.01). Among those who
were not successful from aIVF, 11.1% (n¼4) endorsed no regret, 44.4%
(n¼16) had mild regret, and 44.4% (n¼16) had moderate/severe regret. Of
those who failed aIVF but was then successful with donor eggs (n¼12),
50.0% (n¼6) still reported moderate/severe regret.
CONCLUSIONS: There is a considerable risk of decision regret following
aIVF in women age 42 and over. Degree of regret was influenced by insurance coverage for IVF and strongly associated with whether a live birth
was achieved. Regret was not eliminated in those who then became successful through donor eggs. Providers should discuss this risk as part of the
informed consent. Further data, particularly from those who were unsuccessful, is needed to substantiate these results and identify additional predictors
for moderate/severe regret in order to improve patient counseling.
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TOP TEN RESEARCH PRIORITIES FOR ETHICS,
ACCESS, AND ORGANISATION OF FERTILITY
CARE. James M. N. Duffy, DPhil MRes PG HCL MBChB
BSc (Hons),1 Barbara Lynn Collura, MA,2 Cindy Farquhar,
FRANZCOG FRCOG MD MPH,3 Priority Setting Partnership for Infertility1Institute for Women’s Health, University College London, Greater London, United Kingdom; 2RESOLVE: The National Infertility Association,
McLean, VA; 3University of Auckland, Auckland, New Zealand.
OBJECTIVE: To develop the top 10 research priorities for ethics, access,
and organization of fertility care.
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